Abbott’s Libre Duo gets FDA authorization as continuous glucose monitoring expands into ketone detection
Abbott’s Libre Duo 10 Day has received FDA De Novo authorization as the first integrated continuous glucose and ketone monitoring system in the United States, potentially extending CGM from daily glucose control into early diabetic ketoacidosis warning.